====================================================================================================
           GRAPH OF THOUGHTS (GoT) BIOMEDICAL QUERY RESULTS           
====================================================================================================

Query: What are the genetic factors that influence the efficacy of antipsychotic
       drugs      in treating schizophrenia, and how do these genetic variations
       affect dopamine receptor pathways      and drug metabolism? Include
       information about personalized medicine approaches.
Timestamp: 2025-10-01 08:24:24

üìã EXECUTIVE SUMMARY
--------------------------------------------------
Status: ‚úÖ SUCCESS
Execution Time: 688.557s
Entities Found: 11
Total Results: 201
Quality Score: 0.278
Execution Steps: 10
GoT Volume: 10 thoughts
GoT Latency: 4 hops

üéØ FINAL ANSWER
--------------------------------------------------
### Genetic Factors Influencing Antipsychotic Efficacy in Schizophrenia  The
efficacy of antipsychotic drugs in treating schizophrenia is significantly
influenced by genetic factors. Variations in specific genes can affect both the
pharmacodynamics (how the drug affects the body) and pharmacokinetics (how the
body processes the drug) of these medications, particularly through their
interactions with dopamine receptor pathways and drug metabolism.  #### Key
Genetic Variations  1. **Dopamine Receptor Genes**:     - Variants in genes
encoding dopamine receptors (e.g., DRD2, DRD3) are known to influence the
response to antipsychotic medications. For instance, polymorphisms in the DRD2
gene can affect receptor sensitivity and, consequently, the therapeutic efficacy
of drugs targeting these receptors.    - Evidence suggests that genetic
variations in these receptors can lead to differential responses to
antipsychotics, impacting treatment outcomes (confidence score: low).  2. **Drug
Metabolism Genes**:    - Genes involved in drug metabolism, such as those coding
for cytochrome P450 enzymes (e.g., CYP2D6, CYP3A4), play a crucial role in the
pharmacokinetics of antipsychotic drugs. Variations in these genes can lead to
altered drug metabolism, affecting drug levels in the body and, ultimately,
therapeutic efficacy.    - For example, individuals with certain polymorphisms
may metabolize drugs more slowly, leading to increased side effects or
therapeutic failure (confidence score: low).  #### Impact on Dopamine Pathways
- **Dopamine Pathway Modulation**:     - Antipsychotic drugs primarily target
dopamine pathways, which are crucial in the pathophysiology of schizophrenia.
Genetic variations can modulate these pathways, influencing both the efficacy
and side effect profiles of treatments.    - For instance, individuals with
specific DRD2 variants may experience more significant symptom relief from
dopamine antagonists, while others may not respond as favorably, highlighting
the importance of personalized medicine approaches (confidence score: low).
#### Personalized Medicine Approaches  - **Tailored Treatment Strategies**:
- The integration of pharmacogenomics into clinical practice allows for more
personalized treatment strategies. By assessing an individual's genetic profile,
clinicians can predict which antipsychotic medications are likely to be most
effective and which may pose a higher risk of adverse effects.    - For example,
genetic testing for polymorphisms in drug metabolism genes can guide dosage
adjustments or the selection of alternative medications to optimize therapeutic
outcomes (confidence score: low).  #### Limitations and Future Directions  -
**Evidence Quality**:     - The current evidence regarding genetic factors
influencing antipsychotic efficacy is primarily of low confidence, indicating a
need for further research to establish stronger associations and mechanisms.
- While some genetic variations have been identified, the complexity of
schizophrenia and the multifactorial nature of drug response necessitate larger,
well-designed studies to validate these findings.  - **Emerging Research**:
- Ongoing studies are exploring the role of additional genetic factors,
including those related to neurotransmitter systems beyond dopamine, as well as
epigenetic influences that may affect treatment response.    - Future research
should focus on integrating genetic data with clinical outcomes to refine
personalized medicine approaches in schizophrenia treatment.  ### Conclusion  In
summary, genetic factors significantly influence the efficacy of antipsychotic
drugs in treating schizophrenia, particularly through their effects on dopamine
receptor pathways and drug metabolism. While current evidence is primarily of
low confidence, the potential for personalized medicine approaches based on
genetic profiling holds promise for improving treatment outcomes in individuals
with schizophrenia. Continued research is essential to enhance our understanding
of these genetic influences and to develop more effective, tailored therapeutic
strategies.

üóÇÔ∏è  QUERY EXECUTION PLAN
--------------------------------------------------
Execution Flow:

üîç Entity Extraction ‚úÖ
   Time: 80.142s, Confidence: 0.85
    ‚Üì
    üõ†Ô∏è  Query Building ‚úÖ
       Time: 12.133s, Confidence: 0.80
    ‚Üì
    üåê Api Execution ‚úÖ
       Time: 0.000s, Confidence: 0.27
    ‚Üì
    üõ†Ô∏è  Query Building ‚úÖ
       Time: 4.103s, Confidence: 0.80
    ‚Üì
    üåê Api Execution ‚úÖ
       Time: 0.000s, Confidence: 0.27
    ‚Üì
    üõ†Ô∏è  Query Building ‚úÖ
       Time: 4.864s, Confidence: 0.80
    ‚Üì
    üåê Api Execution ‚úÖ
       Time: 0.000s, Confidence: 0.24
    ‚Üì
    üõ†Ô∏è  Query Building ‚úÖ
       Time: 5.648s, Confidence: 0.80
    ‚Üì
    üåê Api Execution ‚úÖ
       Time: 0.000s
    ‚Üì
    üìä Aggregation ‚úÖ
       Time: 0.004s, Confidence: 0.28

üìñ STEP-BY-STEP RESULTS
--------------------------------------------------

1. Entity Extraction ‚úÖ
   Step ID: entity_extraction_1759331575
   Execution Time: 80.142s
   Confidence: 0.85
   Input: TRAPI query
   Output: 11 entities
   üìã Entities Found:
      ‚Ä¢ genetic factors (general) - ID: EFO:0004828, Conf: 0.85
      ‚Ä¢ efficacy (general) - ID: UMLS:C0087113, Conf: 0.85
      ‚Ä¢ antipsychotic drugs (drug) - ID: UMLS:C0040615, Conf: 0.85
      ‚Ä¢ schizophrenia (disease) - ID: UMLS:C0036341, Conf: 0.85
      ‚Ä¢ genetic variations (general) - ID: UMLS:C0042333, Conf: 0.85

2. Query Building ‚úÖ
   Step ID: query_building_1759331661_subq_0
   Execution Time: 12.133s
   Confidence: 0.80
   Input: 4 entities
   Output: TRAPI query

3. Api Execution ‚úÖ
   Step ID: api_execution_1759332122_pred_related_to_subq_0
   Execution Time: 0.000s
   Confidence: 0.27
   Input: dict with 3 keys
   Output: 100 results
   üìä API Results: 100 total
      Result 1: result_1 (score: 0.265)
        Nodes: 0, Edges: 0
      Result 2: result_2 (score: 0.265)
        Nodes: 0, Edges: 0
      Result 3: result_3 (score: 0.265)
        Nodes: 0, Edges: 0

4. Query Building ‚úÖ
   Step ID: query_building_1759332122_subq_1
   Execution Time: 4.103s
   Confidence: 0.80
   Input: 3 entities
   Output: TRAPI query

5. Api Execution ‚úÖ
   Step ID: api_execution_1759332141_pred_related_to_subq_1
   Execution Time: 0.000s
   Confidence: 0.27
   Input: dict with 3 keys
   Output: 100 results
   üìä API Results: 100 total
      Result 1: result_1 (score: 0.290)
        Nodes: 0, Edges: 0
      Result 2: result_2 (score: 0.285)
        Nodes: 0, Edges: 0
      Result 3: result_3 (score: 0.280)
        Nodes: 0, Edges: 0

6. Query Building ‚úÖ
   Step ID: query_building_1759332141_subq_2
   Execution Time: 4.864s
   Confidence: 0.80
   Input: 4 entities
   Output: TRAPI query

7. Api Execution ‚úÖ
   Step ID: api_execution_1759332233_pred_related_to_subq_2
   Execution Time: 0.000s
   Confidence: 0.24
   Input: dict with 3 keys
   Output: 1 results
   üìä API Results: 1 total
      Result 1: result_1 (score: 0.245)
        Nodes: 0, Edges: 0

8. Query Building ‚úÖ
   Step ID: query_building_1759332233_subq_3
   Execution Time: 5.648s
   Confidence: 0.80
   Input: 5 entities
   Output: TRAPI query

9. Api Execution ‚úÖ
   Step ID: api_execution_1759332243_pred_related_to_subq_3
   Execution Time: 0.000s
   Input: dict with 3 keys
   Output: 0 results
   üìä API Results: 0 total

10. Aggregation ‚úÖ
   Step ID: aggregation_1759332243
   Execution Time: 0.004s
   Confidence: 0.28
   Input: 11 entities
   Output: dict with 6 keys
   üîÑ Aggregation Summary:
      Conflicts Resolved: 0
      Duplicates Removed: 0
      Final Results: 201
      Top Result Score: 0.000

üêõ TRAPI QUERY DEBUGGING
--------------------------------------------------

TRAPI Query 1 (query_building):
Step ID: query_building_1759331661_subq_0
```json
{
  "message": {
    "query_graph": {
      "nodes": {
        "n0": {
          "categories": [
            "biolink:Gene"
          ]
        },
        "n1": {
          "categories": [
            "biolink:SmallMolecule"
          ],
          "ids": [
            "UMLS:C0040615"
          ]
        },
        "n2": {
          "categories": [
            "biolink:Disease"
          ],
          "ids": [
            "UMLS:C0036341"
          ]
        }
      },
      "edges": {
        "e01": {
          "subject": "n0",
          "object": "n1",
          "predicates": [
            "biolink:affects"
          ]
        },
        "e02": {
          "subject": "n1",
          "object": "n2",
          "predicates": [
            "biolink:treats"
          ]
        }
      }
    }
  }
}
```
Query Graph: 3 nodes, 2 edges
Nodes:
  n0: Unnamed (biolink:Gene)
  n1: Unnamed (biolink:SmallMolecule)
  n2: Unnamed (biolink:Disease)
Edges:
  e01: n0 ‚Üí n1 (biolink:affects)
  e02: n1 ‚Üí n2 (biolink:treats)

TRAPI Query 2 (query_building):
Step ID: query_building_1759332122_subq_1
```json
{
  "message": {
    "query_graph": {
      "nodes": {
        "n0": {
          "categories": [
            "biolink:Gene"
          ],
          "ids": [
            "UMLS:C0042333"
          ]
        },
        "n1": {
          "categories": [
            "biolink:PhysiologicalProcess"
          ]
        }
      },
      "edges": {
        "e01": {
          "subject": "n0",
          "object": "n1",
          "predicates": [
            "biolink:affects"
          ]
        }
      }
    }
  }
}
```
Query Graph: 2 nodes, 1 edges
Nodes:
  n0: Unnamed (biolink:Gene)
  n1: Unnamed (biolink:PhysiologicalProcess)
Edges:
  e01: n0 ‚Üí n1 (biolink:affects)

TRAPI Query 3 (query_building):
Step ID: query_building_1759332141_subq_2
```json
{
  "message": {
    "query_graph": {
      "nodes": {
        "n0": {
          "categories": [
            "biolink:Gene"
          ],
          "ids": [
            "UMLS:C0042333"
          ]
        },
        "n1": {
          "categories": [
            "biolink:SmallMolecule"
          ],
          "ids": [
            "UMLS:C0040615"
          ]
        }
      },
      "edges": {
        "e01": {
          "subject": "n0",
          "object": "n1",
          "predicates": [
            "biolink:affects"
          ]
        }
      }
    }
  }
}
```
Query Graph: 2 nodes, 1 edges
Nodes:
  n0: Unnamed (biolink:Gene)
  n1: Unnamed (biolink:SmallMolecule)
Edges:
  e01: n0 ‚Üí n1 (biolink:affects)

TRAPI Query 4 (query_building):
Step ID: query_building_1759332233_subq_3
```json
{
  "message": {
    "query_graph": {
      "nodes": {
        "n0": {
          "categories": [
            "biolink:Gene"
          ],
          "ids": [
            "EFO:0004828"
          ]
        },
        "n1": {
          "categories": [
            "biolink:SmallMolecule"
          ],
          "ids": [
            "UMLS:C0040615"
          ]
        }
      },
      "edges": {
        "e01": {
          "subject": "n0",
          "object": "n1",
          "predicates": [
            "biolink:affects"
          ]
        }
      }
    }
  }
}
```
Query Graph: 2 nodes, 1 edges
Nodes:
  n0: Unnamed (biolink:Gene)
  n1: Unnamed (biolink:SmallMolecule)
Edges:
  e01: n0 ‚Üí n1 (biolink:affects)

üìà GOT FRAMEWORK METRICS
--------------------------------------------------
Volume: 10 thoughts
Latency: 4 hops
Total Thoughts: 10
Quality Improvement: 3.47x
Cost Reduction: 0.80x
Parallel Speedup: 1.20x
Volume-Latency Efficiency: 2.50

Thought Type Distribution:
  entity_extraction: 1 (10.0%)
  query_building: 4 (40.0%)
  api_execution: 4 (40.0%)
  aggregation: 1 (10.0%)

====================================================================================================
                      üéâ QUERY EXECUTION COMPLETED SUCCESSFULLY üéâ                     
====================================================================================================

